FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy